Novo Nordisk's shares are down by 18% year to date, significantly lagging the S&P 500. However, the stock might be a ...

Eli Lilly and Company (NYSE:LLY) is among the 12 Best Ethical Companies to Invest in 2025. Eli Lilly and Company (NYSE:LLY) ...

Several anti-obesity drugs, including Ozempic, Wegovy and Mounjaro, have created buzz in the Indian markets. But are they really approved for use in India? What are their side-effects? And how much do ...

Some patients reluctantly shifted to save money while others have appealed for coverage of Zepbound after having experienced ...

Powerful new medications such as Ozempic and Mounjaro, known as GLP-1 drugs are helping to win the war against obesity in ...

For RFK Jr. and his antivax supporters and associates, aluminum adjuvants in some required children’s vaccines appear to be ...

Dozens of lawmakers are urging US health regulators to crack down on the booming market for knockoff weight-loss drugs amid mounting concerns over their potential safety risks.

Miah’s decade-long battle to be at peace with her body – which she says is due to health concerns rather than body image – has seen her explore a rollercoaster of weightloss methods, from fad diets to ...

This article delves into the approved weight loss drugs in India, their costs, and the growing market for such medications.

The study found that GLP-1 medications, in particular, showed significant weight regain after treatment discontinuation.

(Reuters) -West Pharmaceutical raised its annual profit forecast and trimmed its estimates for tariff impact on Thursday, sending the medical equipment maker's shares up 24% in early trading. West ...